Rapid diagnostic tests for defining the cause of community-acquired pneumonia

Current Opinion in Infectious Diseases

Volumn 28, Issue 2, 2015, Pages 185-192

  Basnayake, Thilini L ^a   Waterer, Grant W ^b,c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cause; Diagnostics; Empiric therapy; Pneumonia

Indexed keywords

ACCURACY; BLOOD CULTURE; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EPIDEMIOLOGICAL DATA; FILMARRAY; GENEXPERT; GRAM STAINING; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; IMMUNOASSAY; MALARIA RAPID TEST; MASS SPECTROMETRY; MICROSCOPY; NEXT GENERATION SEQUENCING; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION TEST; PHYSICIAN; RAPID INFLUENZA TEST; RELIABILITY; REVIEW; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; MOLECULAR DIAGNOSIS; PNEUMONIA; PROCEDURES; TIME;

COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; MASS SPECTROMETRY; MICROSCOPY; MOLECULAR DIAGNOSTIC TECHNIQUES; PNEUMONIA; TIME FACTORS;

EID: 84926383647     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000148     Document Type: Review

References (52)

1. Wunderink RG, Waterer GW. Clinical practice. Community-acquired pneumonia. N Engl J Med 2014; 370:543-551.
2. Smith SB, Ruhnke GW, Weiss CH, et al. Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011. JAMA Intern Med 2014; 174:1837-1839.
3. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for healthcare-associated pneumonia. Arch Intern Med 2008; 168:2205-2210.
4. Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis 2013; 57:e22-e121.
5. Ewig S, Welte T, Torres A. Is healthcare-associated pneumonia a distinct entity needing specific therapy? Curr Opin Infect Dis 2012; 25:166-175.
6. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in healthcare-associated pneumonia: A UK cohort study. Clin Infect Dis 2011; 53:107-113.
7. Reed WW, Byrd GS, Gates RH Jr, et al. Sputum Gram's stain in communityacquired pneumococcal pneumonia. A meta-analysis. West J Med 1996; 165:197-204.
8. Roson B, Carratala J, Verdaguer R, et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31:869-874.
9. Miyashita N, Shimizu H, Ouchi K, et al. Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit 2008; 14:CR171-CR176.
10. Anevlavis S, Petroglou N, Tzavaras A, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect 2009; 59:83-89.
11. Song JY, Eun BW, Nahm MH. Diagnosis of pneumococcal pneumonia: Current pitfalls and the way forward. Infect Chemother 2013; 45:351-366.
12. Garin N, Genne D, Carballo S, et al. b-Lactam monotherapy vs b-lactammacrolide combination treatment in moderately severe community-acquired pneumonia: A randomized noninferiority trial. JAMA Intern Med 2014; 174:1894-1901.
13. Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006; 19:788-802.
14. Waterer GW, Jennings SG, Wunderink RG. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999; 116:1278-1281.
15. Chalasani NP, Valdecanas MA, Gopal AK, et al. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 1995; 108:932-936.
16. Afshar N, Tabas J, Afshar K, Silbergleit R. Blood cultures for communityacquired pneumonia: Are they worthy of two quality measures? A systematic review. J Hosp Med 2009; 4:112-123.
17. Waterer GW, Lopez D. Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect. Eur Respir J 2012; 39:7-8.
18. Piso RJ, Iven-Koller D, Koller MT, Bassetti S. The routine use of urinary pneumococcal antigen test in hospitalised patients with community acquired pneumonia has limited impact for adjustment of antibiotic treatment. Swiss Med Wkly 2012; 142:w13679.
19. Horita N, Miyazawa N, Kojima R, et al. Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: A meta-analysis. Respirology 2013; 18:1177-1183.
20. Charkaluk ML, Kalach N, Mvogo H, et al. Assessment of a rapid urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal infection in children. Diagn Microbiol Infect Dis 2006; 55:89-94.
21. Dominguez J, Blanco S, Rodrigo C, et al. Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol 2003; 41:2161-2163.
22. Dowell SF, Garman RL, Liu G, et al. Evaluation of BinaxNOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis 2001; 32:824-825.
23. Andreo F, Prat C, Ruiz-Manzano J, et al. Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2009; 28:197-201.
24. Sinclair A, Xie X, Teltscher M, Dendukuri N. Systematic review and metaanalysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol 2013; 51:2303-2310.
25. Sorde R, Falco V, Lowak M, et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med 2011; 171:166-172.
26. Pride MW, Huijts SM,WuK, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol 2012; 19:1131-1141.
27. Aziz M, Vasoo S, Aziz Z, et al. Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria. Scand J Infect Dis 2012; 44:306-311.
28. Gao F, Loring C, Laviolette M, et al. Detection of 2009 pandemic influenza A(H1N1) virus Infection in different age groups by using rapid influenza diagnostic tests. Influenza Other Respir Viruses 2012; 6:e30-e34.
29. Nutter S, Cheung M, Adler-Shohet FC, et al. Evaluation of indirect fluorescent antibody assays compared to rapid influenza diagnostic tests for the detection of pandemic influenza A (H1N1) pdm09. PLoS One 2012; 7:e33097.
30. Ciblak MA, Kanturvardar M, Asar S, et al. Sensitivity of rapid influenza antigen tests in the diagnosis of pandemic (H1N1)2009 compared with the standard rRT-PCR technique during the 2009 pandemic in Turkey. Scand J Infect Dis 2010; 42:902-905.
31. Ganzenmueller T, Kluba J, Hilfrich B, et al. Comparison of the performance of direct fluorescent antibody staining, a point-of-care rapid antigen test and virus isolation with that of RT-PCR for the detection of novel 2009 influenza A (H1N1) virus in respiratory specimens. J Med Microbiol 2010; 59:713-717.
32. Chartrand C, Leeflang MM, Minion J, et al. Accuracy of rapid influenza diagnostic tests: A meta-analysis. Ann Intern Med 2012; 156:500-511.
33. Nicholson KG, Abrams KR, Batham S, et al. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18-to 64-yearolds. Health Technol Assess 2014; 18:1-274; vii-viii.
34. Peci A, Winter AL, King EC, et al. Performance of rapid influenza diagnostic testing in outbreak settings. J Clin Microbiol 2014; 52:4309-4317.
35. Busson L, Hallin M, Thomas I, et al. Evaluation of 3 rapid influenza diagnostic tests during the 2012-2013 epidemic: influences of subtype and viral load. Diagn Microbiol Infect Dis 2014; 80:287-291.
36. Rello J, Lisboa T, Lujan M, et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009; 136:832-840.
37. Werno AM, Anderson TP, Murdoch DR. Association between pneumococcal load and disease severity in adults with pneumonia. J Med Microbiol 2012; 61:1129-1135.
38. Munoz-Almagro C, Gala S, Selva L, et al. DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema. Eur J Clin Microbiol Infect Dis 2011; 30:327-335.
39. Dangerfield B, Chung A, Webb B, Seville MT. Predictive value of methicillinresistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother 2014; 58:859-864.
40. Alby K, Popowitch EB, Miller MB. Comparative evaluation of the Nanosphere Verigene RV assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses. J Clin Microbiol 2013; 51:352-353.
41. Steingart KR, Schiller I, Horne DJ, et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014; CD009593.
42. Miller S, Moayeri M, Wright C, et al. Comparison of GeneXpert FluA PCR to direct fluorescent antibody and respiratory viral panel PCR assays for detection of 2009 novel H1N1 influenza virus. J Clin Microbiol 2010; 48:4684-4685.
43. Patel PA, Schora DM, Peterson KE, et al. Performance of the Cepheid Xpert(R) SA Nasal Complete PCR assay compared to culture for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus colonization. Diagn Microbiol Infect Dis 2014; 80:32-34.
44. Valour F, Blanc-Pattin V, Freydiere AM, et al., Lyon Bone Joint Infection Study G. Rapid detection of Staphylococcus aureus and methicillin resistance in bone and joint infection samples: Evaluation of the GeneXpert MRSA/SA SSTI assay. Diagn Microbiol Infect Dis 2014; 78:313-315.
45. Pierce VM, Elkan M, Leet M, et al. Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children. J Clin Microbiol 2012; 50:364-371.
46. Pulido M, Moreno-Martinez P, Fernandez-Cuenca F, et al. Application of the BioFire FilmArray pneumonia panel for rapid identification of the causative agents of ventilator-associated pneumonia. Presented at the European Society of Clinical Microbiology and Infectious Diseases. 2014. p. 1439.
47. Jamal W, Al Roomi E, AbdulAziz LR, Rotimi VO. Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia. J Clin Microbiol 2014; 52:2487-2492.
48. Schulte B, Eickmeyer H, Heininger A, et al. Detection of pneumonia associated pathogens using a prototype multiplexed pneumonia test in hospitalized patients with severe pneumonia. PLoS One 2014; 9:e110566.
49. Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: The potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 2012; 14:295-304.
50. Greenwood-Quaintance KE, Uhl JR, Hanssen AD, et al. Diagnosis of prosthetic joint infection by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol 2014; 52:642-649.
51. Kaleta EJ, Clark AE, Cherkaoui A, et al. Comparative analysis of PCRelectrospray ionization/mass spectrometry (MS) and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood culture bottles. Clin Chem 2011; 57:1057-1067.
52. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One 2009; 4:e8041.